- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06108011
Effect of Lollipop on Postoperative Gastrointestinal Recovery in Children
Effect of Lollipop on Postoperative Gastrointestinal Recovery in Children: A Randomised Controlled Trial
Study Overview
Detailed Description
Postoperative ileus is a common occurrence among children undergoing major operations, including gastrointestinal and spinal surgeries. It can result in physical discomfort, extended hospital stays, delayed resumption of activity and poor satisfaction with surgical care. The pathophysiology and course of postoperative ileus occurs in three phases: increased sympathetic activity, release of inflammatory mediators and vagal activation as ileus resolves. Multiple risk factors of postoperative ileus have been identified in various studies, including general risk factors such as significant blood loss, male gender and medical comorbidities like chronic obstructive pulmonary disease (COPD), as well as risk factors specific to the surgery, such as the laparotomy approach, emergency surgery and stoma formation.
Chewing gum, as a form of sham feeding, has been employed in adults and children as a modality to decrease risk of postoperative ileus. There has been concrete evidence that it could result in expedited recovery of gastrointestinal function after surgery in adult populations. However, it may not be a feasible option for infants and young children. Lollipop, on the other hand, is easier to apply in children which only require the action of sucking. It can stimulate the cephalic phase of digestion via vagal cholinergic stimulation and release of gastrointestinal hormone (gastrin and motilin) through its taste and absorption of sugar. The current evidence of lollipop in the recovery of postoperative gastrointestinal function in children is limited with only two randomised controlled trial published so far with satisfactory outcomes, yet both were not indexed and were not carried out in accordance with Consolidated Standards of Reporting Trials (CONSORT). Based on these reasons, the investigators plan to carry out a prospective, multiple-centred, non-blinded, randomized controlled trial using a parallel arm design on the effect of lollipop on recovery of gastrointestinal function after operation in children. Children recruited will be randomly assigned into either lollipop group or non-treatment group; lollipop will be given to children in treatment group after operation. Their outcomes will be compared.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients receiving major abdominal surgery (e.g.appendicectomy, choledochal cyst surgery, bowel resection etc)
Exclusion Criteria:
- Patients with neurological conditions that preclude sucking/swallowing.
- Patients under sedation and/or mechanical ventilation and/or ionotropic support in the post operative period.
- Patients with known food allergy or allergy to food coloring agents
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lollipop
Given lollipop 6 hours after operation, sucking of lollipop at least 20mins every 4 hours after operation until feeding is resumed.
|
sucking of lollipop after operation
|
No Intervention: No Lollipop
No placebo would be given
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time for participants to return of flatus
Time Frame: 1 week
|
the time needed for flatus to happen after operation, in term as hours
|
1 week
|
Time for participants to first stool passage
Time Frame: 1 week
|
The time needed for stool passage, in terms of hours
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time for participants to resumption of feeding
Time Frame: 1 month
|
time needed to resume feeding in terms of days
|
1 month
|
Time for participants to discharge from hospital after operation
Time Frame: 1 month
|
in term of days
|
1 month
|
Presence of any complications in participants
Time Frame: 1 month
|
any complication happened because of the treatment
|
1 month
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- LollipopTrial
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ileus Postoperative
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenRecruitingPostoperative IleusBelgium
-
West China HospitalCompletedPostoperative IleusChina
-
Hadassah Medical OrganizationCompleted
-
li xiongUnknown
-
Jinling Hospital, ChinaCompletedPostoperative IleusChina
-
Services Hospital, LahoreCompletedPostoperative IleusPakistan
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompletedPostoperative IleusBelgium
-
Gabriele Baldini, MD, MSc, Assistant ProfessorCompleted
-
Benazir Bhutto Hospital, RawalpindiCompletedPostoperative Ileus.Pakistan
Clinical Trials on Lollipop
-
University of Wisconsin, MadisonCompleted
-
Air Force Military Medical University, ChinaCompleted
-
Air Force Military Medical University, ChinaCompleted
-
University of Wisconsin, MadisonWithdrawn
-
Dana-Farber Cancer InstituteTHOR Photomedicine LtdRecruitingOral Mucositis | Myeloablative Allogeneic Hematopoietic Cell Transplantation | Intraoral Photobiomodulation Therapy | Mucosal UlcerUnited States
-
University of Wisconsin, MadisonNational Institutes of Health (NIH)Recruiting
-
Sahlgrenska University Hospital, SwedenCompleted
-
University of Wisconsin, MadisonCompleted
-
University of Electronic Science and Technology...Recruiting
-
University of Electronic Science and Technology...Recruiting